| Budget Amount *help |
¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2015: ¥130,000 (Direct Cost: ¥100,000、Indirect Cost: ¥30,000)
Fiscal Year 2014: ¥130,000 (Direct Cost: ¥100,000、Indirect Cost: ¥30,000)
Fiscal Year 2013: ¥520,000 (Direct Cost: ¥400,000、Indirect Cost: ¥120,000)
Fiscal Year 2012: ¥650,000 (Direct Cost: ¥500,000、Indirect Cost: ¥150,000)
|
|---|
| Outline of Final Research Achievements |
The purpose of the study was to clarify the appropriate dose constraints of the critical organs in the combination of brachytherapy and intensity-modulated radiation therapy for intermediate/high risk prostate cancer. We examined the dose of each critical organ in the treatment planning of both treatment and the frequency of the adverse events. We showed that this combination therapy was safe without serious adverse event if satisfying the proposed dose constraints for the critical organ (urethra, rectum, bladder and bowel) in each of brachytherapy and IMRT.
|
